NVE Corp Files 8-K/A Amendment
Ticker: NVEC · Form: 8-K/A · Filed: Dec 17, 2025 · CIK: 724910
Sentiment: neutral
Topics: amendment, material-agreement, sec-filing
TL;DR
NVE Corp filed an 8-K/A amendment on Dec 17, 2025, related to a material agreement from Jan 1, 2006.
AI Summary
NVE Corp filed an amendment (8-K/A) on December 17, 2025, to a report originally dated January 1, 2006. This amendment pertains to a material definitive agreement entered into by the company. NVE Corp, incorporated in Minnesota, is involved in the semiconductors & related devices industry.
Why It Matters
This filing indicates an update or correction to a previously disclosed material agreement, which could impact the company's contractual obligations or business relationships.
Risk Assessment
Risk Level: low — The filing is an amendment to a historical report and does not appear to disclose new, immediate risks.
Key Numbers
- 000-12196 — SEC File Number (Identifies the company's filing history with the SEC.)
- 41-1424202 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- NVE Corp (company) — Registrant
- Minnesota (location) — State of incorporation
- December 17, 2025 (date) — Filing date of amendment
- January 1, 2006 (date) — Earliest event reported date
- 11409 Valley View Road, Eden Prairie, Minnesota 55344 (address) — Principal executive offices
FAQ
What specific material definitive agreement is being amended by this 8-K/A filing?
The filing does not specify the exact nature of the material definitive agreement being amended, only that it is an amendment to a report originally dated January 1, 2006.
What is the significance of the filing date being December 17, 2025, for a report originally from January 1, 2006?
The filing date of December 17, 2025, indicates when the amendment was submitted to the SEC, updating or correcting information related to the original January 1, 2006 event.
What industry does NVE Corp operate in?
NVE Corp operates in the Semiconductors & Related Devices industry, with SIC code 3674.
Where are NVE Corp's principal executive offices located?
NVE Corp's principal executive offices are located at 11409 Valley View Road, Eden Prairie, Minnesota 55344.
What is the purpose of an 8-K/A filing?
An 8-K/A filing is an amendment to a previously filed Current Report on Form 8-K, used to correct or update information previously reported.
Filing Stats: 837 words · 3 min read · ~3 pages · Grade level 9 · Accepted 2025-12-17 16:06:53
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value NVEC The NASDAQ Stock Mar
Filing Documents
- nvec-20060101_8kz.htm (8-K/A) — 23KB
- nve_ex10.6.htm (EX-10.6) — 17KB
- nve8kz_1.gif (GRAPHIC) — 1KB
- 0001376474-25-000978.txt ( ) — 163KB
- nvec-20060101_def.xml (EX-101.DEF) — 2KB
- nvec-20060101_lab.xml (EX-101.LAB) — 16KB
- nvec-20060101_pre.xml (EX-101.PRE) — 11KB
- nvec-20060101.xsd (EX-101.SCH) — 2KB
- nvec-20060101_8kz_htm.xml (XML) — 3KB
01. Entry into a Material Definitive Agreement
Item 1.01. Entry into a Material Definitive Agreement. General Information We supply products to Abbott under the Supplier Partnering Agreement as amended. Description of the Terms and Conditions of the Amendment Amendment No. 12 to the Supplier Partnering Agreement was executed on December 12, 2025 extending the Agreement term through December 31, 2027 and increasing pricing for 2026 and 2027. The Amendment is filed as Exhibit 10.6 to this Current Report on Form 8-K/A. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date December 1 7, 2025 NVE CORPORATION (Registrant) /s/ DANIEL A. BAKER Daniel A. Baker President & Chief Executive Officer 3 INDEX TO EXHIBITS Exhibit # Description 10.1 Indemnification Agreement by and between Pacesetter, Inc., a St. Jude Medical Company, d.b.a. St. Jude Medical Cardiac Rhythm Management Division, and the company (incorporated by reference to the Form 8-K filed September 27, 2005). 10.2+ Supplier Partnering Agreement by and between St. Jude and the company (incorporated by reference to the Form 8-K filed January 4, 2006). 10.3 Amendment No. 4 to Supplier Partnering Agreement between St. Jude and the company (incorporated by reference to the Form 8-K/A filed February 7, 2011). 10.4 Amendment No. 5 to Supplier Partnering Agreement between St. Jude and the company (incorporated by reference to the Form 8-K/A filed April 21, 2016). 10.5* Amendment No. 8 to Supplier Partnering Agreement between Abbott and the company (incorporated by reference to the Form 8-K/A filed February 2, 202 2). 10.6* Amendment No. 1 2 to Supplier Partnering Agreement between Abbott and the company (filed with this Current Report on Form 8-K/A). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). +Confidential portions of this exhibit we